Ana Blatnik
Overview
Explore the profile of Ana Blatnik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
188
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kersevan T, Kogovsek T, Blatnik A, Krajc M
Hered Cancer Clin Pract
. 2025 Feb;
23(1):8.
PMID: 39985063
Background: The Department of Clinical Cancer Genetics at the Institute of Oncology Ljubljana offers genetic counselling and testing to cancer patients and their relatives. Before undergoing genetic testing, patients sign...
2.
Mesaric V, Blatnik A, Drusany Staric K, Strojnik K, Stegel V, Hotujec S, et al.
Hum Genomics
. 2024 Dec;
18(1):137.
PMID: 39696405
No abstract available.
3.
Pizem J, Bostjancic E, Zupan A, Salapura V, Mavcic B, Blatnik A, et al.
Virchows Arch
. 2024 Nov;
485(6):1175-1181.
PMID: 39496818
There is an emerging group of distinct vascular neoplasms with NFATC1/2 fusions, involving bones and soft tissues and often displaying focal epithelioid morphology, variable atypia of endothelial cells, predominantly vasoformative...
4.
Skof E, Stegel V, Dragos V, Blatnik A, Gregoric B, Skerl P, et al.
Gynecol Oncol
. 2024 Aug;
190:104-112.
PMID: 39178525
Objective: In patients with platinum-sensitive relapsed ovarian cancer (PSROC) harboring pathogenic/likely pathogenic variants (PV) in BRCA1 and BRCA2 genes, olaparib maintenance monotherapy (OMT) is a viable option. Our study aimed...
5.
Pavlin T, Blatnik A, Seruga B
Front Oncol
. 2024 May;
14:1404706.
PMID: 38817905
Background: Operable triple-negative breast cancer (TNBC) is an unfavorable subtype of breast cancer, which usually requires an aggressive perioperative systemic treatment. When TNBC presents as a second primary cancer after...
6.
Hendricks L, Verbeek K, Schuurs-Hoeijmakers J, Mensenkamp A, Brems H, de Putter R, et al.
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473316
Females with PTEN Hamartoma Tumor Syndrome (PHTS) have breast cancer risks up to 76%. This study assessed associations between breast cancer and lifestyle in European female adult PHTS patients. Data...
7.
Ansari M, Faour K, Shimamura A, Grimes G, Kao E, Denhoff E, et al.
HGG Adv
. 2024 Feb;
5(2):100273.
PMID: 38297832
Heterozygous missense variants and in-frame indels in SMC3 are a cause of Cornelia de Lange syndrome (CdLS), marked by intellectual disability, growth deficiency, and dysmorphism, via an apparent dominant-negative mechanism....
8.
Ansari M, Faour K, Shimamura A, Grimes G, Kao E, Denhoff E, et al.
medRxiv
. 2023 Oct;
PMID: 37808847
Heterozygous missense variants and in-frame indels in are a cause of Cornelia de Lange syndrome (CdLS), marked by intellectual disability, growth deficiency, and dysmorphism, via an apparent dominant-negative mechanism. However,...
9.
Blatnik A, Dragos V, Blatnik O, Stegel V, Klancar G, Novakovic S, et al.
Arch Pathol Lab Med
. 2023 Jun;
148(3):299-309.
PMID: 37270804
Context.—: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and lethal tumor, characterized by hypercalcemia and early onset and associated with germline and somatic SMARCA4 variants....
10.
Garcia-Pelaez J, Barbosa-Matos R, Lobo S, Dias A, Garrido L, Castedo S, et al.
Lancet Oncol
. 2022 Nov;
24(1):91-106.
PMID: 36436516
Background: Truncating pathogenic or likely pathogenic variants of CDH1 cause hereditary diffuse gastric cancer (HDGC), a tumour risk syndrome that predisposes carrier individuals to diffuse gastric and lobular breast cancer....